151 results on '"Castle, John"'
Search Results
2. Bioinformatic methods for cancer neoantigen prediction
3. Data from Exploiting the Mutanome for Tumor Vaccination
4. Supplementary Table 2 from Exploiting the Mutanome for Tumor Vaccination
5. Supplementary Methods from Exploiting the Mutanome for Tumor Vaccination
6. Data from Exploiting the Mutanome for Tumor Vaccination
7. Supplementary Table 1 from Exploiting the Mutanome for Tumor Vaccination
8. Supplementary Table 2 from Exploiting the Mutanome for Tumor Vaccination
9. Supplementary Table 1 from Exploiting the Mutanome for Tumor Vaccination
10. Supplementary Methods from Exploiting the Mutanome for Tumor Vaccination
11. In Silico Typing of Classical and Non-classical HLA Alleles from Standard RNA-Seq Reads
12. Breast cancer cells mediate endothelial cell activation, promoting von Willebrand factor release, tumor adhesion, and transendothelial migration
13. Abstract 3929: Identification of MRT-2359 a potent, selective and orally bioavailable GSPT1-directed molecular glue degrader (MGD) for the treatment of cancers with Myc-induced translational addiction
14. Abstract P5-06-09: Rivaroxaban targets the procoagulant tumour microenvironment in vitro and thereby inhibits breast cancer progression
15. Neoantigen vaccine-induced CD4 T cells confer protective immunity in a mouse model of multiple myeloma through activation of CD8 T cells against non-vaccine, tumor-associated antigens
16. Rivaroxaban targets procoagulant fibroblasts in the tumour microenvironment to reduce breast cancer cell migration and stem cell activity
17. Abstract LBA004: Identification of GSPT1-directed molecular glue degrader (MGD) for the treatment of Myc-driven breast cancer
18. Exploiting the Mutanome for Personalized Cancer Immunotherapy
19. In Silico HLA Typing Using Standard RNA-Seq Sequence Reads
20. Genomics Meets Cancer Immunotherapy
21. Dedication
22. Update on the role of circulating tumour cells in cancer-associated thrombosis
23. 02. A hypercoagulant tumour microenvironment promotes breast cancer progression, with effects inhibited by anticoagulants
24. Current status of use of high throughput nucleotide sequencing in rheumatology
25. Rivaroxaban compared to no treatment in ER-negative stage I–III early breast cancer patients (the TIP Trial): study protocol for a phase II preoperative window-of-opportunity study design randomised controlled trial
26. 05. TARGETING THE PROCOAGULANT TUMOUR MICROENVIRONMENT IN BREAST CANCER
27. Abstract P5-04-27: The relationship between tumour associated macrophage markers and tumour, demographic & behavioural factors in breast cancer
28. Breast cancer stromal clotting activation (Tissue Factor and thrombin): A pre‐invasive phenomena that is prognostic in invasion
29. Results of XPAND II: A Multicenter, Prospective, Continued-Access Clinical Trial Using the AeroForm Tissue Expander for Two-Stage Breast Reconstruction
30. Integration of Spatial Analysis in Long-Term Ecological Studies
31. Integration of Spatial Analysis in Long-Term Ecological Studies
32. Correction to: Angiosarcoma patients treated with immune checkpoint inhibitors: a case series of seven patients from a single institution
33. Human Leukocyte Antigen Typing Using High-Throughput DNA and RNA Sequencing and Application for Cell Line Identification
34. TCR Fingerprinting and Off-Target Peptide Identification
35. Angiosarcoma patients treated with immune checkpoint inhibitors: a case series of seven patients from a single institution
36. Mutation-Derived Neoantigens for Cancer Immunotherapy
37. Withdrawal: Identification of tumor antigens among the HLA peptidomes of glioblastoma tumors and plasma.
38. Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma
39. Publisher Correction: Actively personalized vaccination trial for newly diagnosed glioblastoma
40. Actively personalized vaccination trial for newly diagnosed glioblastoma
41. Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma
42. Responsiveness to anti-PD-1 and anti-CTLA-4 immune checkpoint blockade in SB28 and GL261 mouse glioma models
43. Designing a Path to an Economically, Socially and Environmentally Sustainable Plan for Accessible Storage at Winterthur Museum, Garden and Library
44. Coagulation as a pharmacodynamic biomarker in breast cancer: Changes in tumour expression of extrinsic clotting factors in response to breast cancer treatment
45. Update for Thrombin Inhibition Preoperatively (TIP) in early breast cancer, the first clinical trial of DOACs as an anti-cancer agent
46. Extrinsic clotting pathway markers predict survival in early breast cancer
47. Evidence for the role of procoagulant stromal fibroblasts in the progression of Ductal Carcinoma in Situ
48. HLA and proteasome expression body map
49. Enhanced protection of C57 BL/6 vs Balb/c mice to melanoma liver metastasis is mediated by NK cells
50. Abstract: Results of the XPAND II Multi-Center, Prospective Clinical Trial for the AeroForm Tissue Expander System used for Two-Stage Breast Reconstruction
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.